NeutriSci International Inc (V:NU) — Market Cap & Net Worth
Market Cap & Net Worth: NeutriSci International Inc (NU)
NeutriSci International Inc (V:NU) has a market capitalization of $892.12K (CA$1.23 Million) as of September 15, 2026. Listed on the V stock exchange, this Canada-based company holds position #30778 globally and #1596 in its home market, demonstrating a 10.77% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NeutriSci International Inc's stock price CA$15.02 by its total outstanding shares 178424000 (178.42 Million). Also see NeutriSci International Inc asset portfolio for a full breakdown of the balance sheet.
NeutriSci International Inc Market Cap History: 2015 to 2026
NeutriSci International Inc's market capitalization history from 2015 to 2026. Data shows growth from $20.01 Million to $1.94 Billion (50.44% CAGR). Also see NeutriSci International Inc cash conversion from operations for how efficiently the company converts equity into cash flow.
NeutriSci International Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NeutriSci International Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest NeutriSci International Inc stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
10.76x
NeutriSci International Inc's market cap is 10.76 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $20.01 Million | $27.79K | -$4.01 Million | 719.78x | N/A |
| 2016 | $19.36 Million | $125.35K | -$2.56 Million | 154.45x | N/A |
| 2017 | $34.20 Million | $151.07K | -$2.12 Million | 226.40x | N/A |
| 2018 | $10.33 Million | $82.66K | -$2.38 Million | 124.91x | N/A |
| 2019 | $3.23 Million | $96.54K | -$1.61 Million | 33.42x | N/A |
| 2020 | $16.78 Million | $74.57K | -$1.95 Million | 225.00x | N/A |
| 2021 | $7.10 Million | $80.89K | -$1.57 Million | 87.75x | N/A |
| 2022 | $1.94 Million | $457.75K | -$770.69K | 4.23x | N/A |
| 2023 | $645.35K | $59.98K | -$552.45K | 10.76x | N/A |
Competitor Companies of NU by Market Capitalization
Companies near NeutriSci International Inc in the global market cap rankings as of September 15, 2026. Review tangible net worth ratio of NeutriSci International Inc to assess the quality of the company's equity after excluding intangible assets.
Key companies related to NeutriSci International Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #520 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #632 globally with a market cap of $44.03 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #640 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Haleon plc (NYSE:HLN): Ranked #678 globally with a market cap of $40.47 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #520 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #632 | GALDERMA GROUP AG | NYSE:GALDY | $44.03 Billion | $37.76 |
| #640 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €15.40 |
| #678 | Haleon plc | NYSE:HLN | $40.47 Billion | $9.19 |
NeutriSci International Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, NeutriSci International Inc's market cap moved from $20.01 Million to $ 1.94 Billion, with a yearly change of 50.44%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$1.94 Billion | -10.27% |
| 2025 | CA$2.16 Billion | +61.43% |
| 2024 | CA$1.34 Billion | +207300.00% |
| 2023 | CA$645.35K | -66.67% |
| 2022 | CA$1.94 Million | -72.73% |
| 2021 | CA$7.10 Million | -57.69% |
| 2020 | CA$16.78 Million | +420.00% |
| 2019 | CA$3.23 Million | -68.75% |
| 2018 | CA$10.33 Million | -69.81% |
| 2017 | CA$34.20 Million | +76.67% |
| 2016 | CA$19.36 Million | -3.23% |
| 2015 | CA$20.01 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 14th, 2026 the market cap of NeutriSci International Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $892.12K USD |
| MoneyControl | $892.12K USD |
| MarketWatch | $892.12K USD |
| marketcap.company | $892.12K USD |
| Reuters | $892.12K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About NeutriSci International Inc
NeutriSci International Inc. develops and markets nutraceutical products in Canada, Germany, and Japan. It offers neuenergy, an energy tab designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail storefront and online markets. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.